"Designing Growth Strategies is in our DNA"

India Womens Health Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Application (Contraceptive Drugs, Dysmenorrhea Therapeutics, Antibiotics, Antifungals, Hormone Replacement, Acne Treatment, Bone Health, and Others) and Forecast, 2022-2029

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106814

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Women’s Diseases, India, 2021
    2. New Product Launches
    3. Key Industry Developments – Mergers, Acquisitions, and Partnerships
    4. Impact of Covid-19 on India Women’s Health Therapeutics Market
  5. India Women’s Health Therapeutics Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Application
      1. Contraceptive Drugs
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      2. Dysmenorrhea Therapeutics
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      3. Antibiotics
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      4. Antifungals
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      5. Hormone Replacement
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      6. Acne Treatment
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      7. Bone Health
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
      8. Others
  6. Competitive Analysis
    1. India Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Dr. Reddy’s Laboratories Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Cipla Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Abbott
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Lupin
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Bayer AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Torrent Pharmaceuticals Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Glenmark Pharmaceuticals Limited
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Granules India Limited
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Emami Limited
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Table 01: India Women’s Health Therapeutics Market Revenue (USD billion) Forecast, By Application, 2018–2029

  • 2018-2029
  • 2021
  • 2018-2020
  • 86
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase